Desenvolvimento de nanocápsulas contendo cetoprofeno e avaliação in vitro da citotoxicidade

Detalhes bibliográficos
Ano de defesa: 2013
Autor(a) principal: Ribas, Daniele Adriane
Orientador(a): Não Informado pela instituição
Banca de defesa: Não Informado pela instituição
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
dARK ID: ark:/26339/0013000009dhd
Idioma: por
Instituição de defesa: Universidade Federal de Santa Maria
BR
Farmacologia
UFSM
Programa de Pós-Graduação em Ciências Farmacêuticas
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
Link de acesso: http://repositorio.ufsm.br/handle/1/5989
Resumo: The aim of this work was to prepare, characterize and evaluate the in vitro cytotoxicity of Eudragit S100® nanocapsules (NC) containing ketoprofen. The nanostructured suspensions were prepared in triplicate by the method of interfacial deposition of preformed polymer. Caprilic/capric triglyceride or rosehip oil were used as the oil core in the preparation of such formulations. Previously, tests of swelling/dissolution of the films of Eudragit S100® were performed and showed the feasibility of using both oils as the core of the NC. The results of the physico-chemical characterization of the systems (pH, size, zeta potential, content, encapsulation efficiency) showed no significant differences between the various types of formulations. The concentration of ketoprofen in the formulations was very close to the theoretical concentration, indicating no loss or degradation of the drug during the preparation process. The encapsulation efficiency of ketoprofen in NC was higher than 90%. The particle size of the formulations was found in the range of 173-197 nm, which is in accordance to the method of preparation employed. Regarding the in vitro release, the mathematical analysis of the profiles showed a first order kinetics with drug diffusion as release mechanism. In order to evaluate the influence of the oil component in the ketoprofen photodegradation, samples were exposed to UVC radiation. The photodegradation was less evident in the rosehip oil NC, probably due to the greatest antioxidant potential of this oil. The in vitro cytotoxicity assay evaluated the viability of 3T3 cell line against four concentrations of ketoprofen (1, 10, 50 and 100 μM) for 24 and 48 hours. After 48 hours of exposure, there was a reduction in cell viability in all tested groups. However, this decrease was not significantly different from the control group. Thus, the prepared formulations can be considered promising alternatives for the delivery of ketoprofen in inflammatory diseases such as rheumatoid arthritis.
id UFSM_dc7091d9a35aaa80029300143434efa4
oai_identifier_str oai:repositorio.ufsm.br:1/5989
network_acronym_str UFSM
network_name_str Manancial - Repositório Digital da UFSM
repository_id_str
spelling Desenvolvimento de nanocápsulas contendo cetoprofeno e avaliação in vitro da citotoxicidadeDevelopment of nanocapsules containing ketoprofen and in vitro evaluation of cytotoxicityNanopartículasNanocápsulasCetoprofenoÓleo de rosa mosquetaEudragit S100®CitotoxicidadeNanoparticlesNanocapsulesKetoprofenRosehip oilCytotoxicityCNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIAThe aim of this work was to prepare, characterize and evaluate the in vitro cytotoxicity of Eudragit S100® nanocapsules (NC) containing ketoprofen. The nanostructured suspensions were prepared in triplicate by the method of interfacial deposition of preformed polymer. Caprilic/capric triglyceride or rosehip oil were used as the oil core in the preparation of such formulations. Previously, tests of swelling/dissolution of the films of Eudragit S100® were performed and showed the feasibility of using both oils as the core of the NC. The results of the physico-chemical characterization of the systems (pH, size, zeta potential, content, encapsulation efficiency) showed no significant differences between the various types of formulations. The concentration of ketoprofen in the formulations was very close to the theoretical concentration, indicating no loss or degradation of the drug during the preparation process. The encapsulation efficiency of ketoprofen in NC was higher than 90%. The particle size of the formulations was found in the range of 173-197 nm, which is in accordance to the method of preparation employed. Regarding the in vitro release, the mathematical analysis of the profiles showed a first order kinetics with drug diffusion as release mechanism. In order to evaluate the influence of the oil component in the ketoprofen photodegradation, samples were exposed to UVC radiation. The photodegradation was less evident in the rosehip oil NC, probably due to the greatest antioxidant potential of this oil. The in vitro cytotoxicity assay evaluated the viability of 3T3 cell line against four concentrations of ketoprofen (1, 10, 50 and 100 μM) for 24 and 48 hours. After 48 hours of exposure, there was a reduction in cell viability in all tested groups. However, this decrease was not significantly different from the control group. Thus, the prepared formulations can be considered promising alternatives for the delivery of ketoprofen in inflammatory diseases such as rheumatoid arthritis.O objetivo deste trabalho foi preparar, caracterizar e avaliar in vitro a citotoxicidade de nanocápsulas (NC) de Eudragit S100® contendo cetoprofeno. As suspensões nanoestruturadas foram preparadas em triplicata pelo método de deposição interfacial do polímero pré-formado. Triglicerídeos de cadeia média (TCM) ou óleo de rosa mosqueta (ORM) foram utilizados como núcleo oleoso na preparação de tais formulações. Previamente, foram realizados testes de inchamento/dissolução dos filmes de Eudragit S100®, os quais revelaram a viabilidade do emprego de ambos os óleos como núcleo das NC. Os resultados da caraterização físico-química dos sistemas (pH, tamanho, potencial zeta, teor, eficiência de encapsulamento) não demonstraram diferenças consideráveis entre os diferentes tipos de formulações. O teor de cetoprofeno nas suspensões nanoestruturadas foi muito próximo à concentração teórica, indicando ausência de perda ou degradação do fármaco durante o processo de preparação. Obteve-se uma taxa de associação do cetoprofeno às NC superior a 90%. O tamanho de partícula nas formulações encontrou-se na faixa de 173 a 197 nm, resultados compatíveis com o método de preparação empregado. Quanto à liberação in vitro, a análise matemática dos perfis demonstrou uma cinética de primeira ordem com difusão do fármaco como mecanismo de liberação. A fim de avaliar a influência do componente oleoso frente à fotodegradação do cetoprofeno, amostras foram expostas à radiação UVC. A fotodegradação foi menos evidente nas NC contendo ORM como núcleo, possivelmente pelo maior potencial antioxidante deste óleo. O teste de citotoxicidade in vitro avaliou a sobrevivência de fibroblastos da linhagem 3T3 frente a quatro concentrações de cetoprofeno (1, 10, 50 e 100 μM) em 24 e 48 horas. Após 48h de exposição, observou-se uma redução da viabilidade celular para todos os grupos testados. Contudo, esta diminuição não foi diferente significativamente do grupo controle. Desta forma, as formulações preparadas podem ser consideradas promissoras para veiculação do cetoprofeno em doenças como a artrite reumatoide.Universidade Federal de Santa MariaBRFarmacologiaUFSMPrograma de Pós-Graduação em Ciências FarmacêuticasCruz, Letíciahttp://lattes.cnpq.br/3095970241017527Silva, Ana Luiza Maurer dahttp://lattes.cnpq.br/8113347790962637Canto, Gizele Scotti dohttp://lattes.cnpq.br/2076175621657265Ribas, Daniele Adriane2015-02-252015-02-252013-08-28info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfapplication/pdfRIBAS, Daniele Adriane. DEVELOPMENT OF NANOCAPSULES CONTAINING KETOPROFEN AND in vitro EVALUATION OF CYTOTOXICITY. 2013. 67 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal de Santa Maria, Santa Maria, 2013.http://repositorio.ufsm.br/handle/1/5989ark:/26339/0013000009dhdporinfo:eu-repo/semantics/openAccessreponame:Manancial - Repositório Digital da UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSM2022-01-31T12:08:34Zoai:repositorio.ufsm.br:1/5989Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/PUBhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.com||manancial@ufsm.bropendoar:2022-01-31T12:08:34Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.none.fl_str_mv Desenvolvimento de nanocápsulas contendo cetoprofeno e avaliação in vitro da citotoxicidade
Development of nanocapsules containing ketoprofen and in vitro evaluation of cytotoxicity
title Desenvolvimento de nanocápsulas contendo cetoprofeno e avaliação in vitro da citotoxicidade
spellingShingle Desenvolvimento de nanocápsulas contendo cetoprofeno e avaliação in vitro da citotoxicidade
Ribas, Daniele Adriane
Nanopartículas
Nanocápsulas
Cetoprofeno
Óleo de rosa mosqueta
Eudragit S100®
Citotoxicidade
Nanoparticles
Nanocapsules
Ketoprofen
Rosehip oil
Cytotoxicity
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
title_short Desenvolvimento de nanocápsulas contendo cetoprofeno e avaliação in vitro da citotoxicidade
title_full Desenvolvimento de nanocápsulas contendo cetoprofeno e avaliação in vitro da citotoxicidade
title_fullStr Desenvolvimento de nanocápsulas contendo cetoprofeno e avaliação in vitro da citotoxicidade
title_full_unstemmed Desenvolvimento de nanocápsulas contendo cetoprofeno e avaliação in vitro da citotoxicidade
title_sort Desenvolvimento de nanocápsulas contendo cetoprofeno e avaliação in vitro da citotoxicidade
author Ribas, Daniele Adriane
author_facet Ribas, Daniele Adriane
author_role author
dc.contributor.none.fl_str_mv Cruz, Letícia
http://lattes.cnpq.br/3095970241017527
Silva, Ana Luiza Maurer da
http://lattes.cnpq.br/8113347790962637
Canto, Gizele Scotti do
http://lattes.cnpq.br/2076175621657265
dc.contributor.author.fl_str_mv Ribas, Daniele Adriane
dc.subject.por.fl_str_mv Nanopartículas
Nanocápsulas
Cetoprofeno
Óleo de rosa mosqueta
Eudragit S100®
Citotoxicidade
Nanoparticles
Nanocapsules
Ketoprofen
Rosehip oil
Cytotoxicity
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
topic Nanopartículas
Nanocápsulas
Cetoprofeno
Óleo de rosa mosqueta
Eudragit S100®
Citotoxicidade
Nanoparticles
Nanocapsules
Ketoprofen
Rosehip oil
Cytotoxicity
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
description The aim of this work was to prepare, characterize and evaluate the in vitro cytotoxicity of Eudragit S100® nanocapsules (NC) containing ketoprofen. The nanostructured suspensions were prepared in triplicate by the method of interfacial deposition of preformed polymer. Caprilic/capric triglyceride or rosehip oil were used as the oil core in the preparation of such formulations. Previously, tests of swelling/dissolution of the films of Eudragit S100® were performed and showed the feasibility of using both oils as the core of the NC. The results of the physico-chemical characterization of the systems (pH, size, zeta potential, content, encapsulation efficiency) showed no significant differences between the various types of formulations. The concentration of ketoprofen in the formulations was very close to the theoretical concentration, indicating no loss or degradation of the drug during the preparation process. The encapsulation efficiency of ketoprofen in NC was higher than 90%. The particle size of the formulations was found in the range of 173-197 nm, which is in accordance to the method of preparation employed. Regarding the in vitro release, the mathematical analysis of the profiles showed a first order kinetics with drug diffusion as release mechanism. In order to evaluate the influence of the oil component in the ketoprofen photodegradation, samples were exposed to UVC radiation. The photodegradation was less evident in the rosehip oil NC, probably due to the greatest antioxidant potential of this oil. The in vitro cytotoxicity assay evaluated the viability of 3T3 cell line against four concentrations of ketoprofen (1, 10, 50 and 100 μM) for 24 and 48 hours. After 48 hours of exposure, there was a reduction in cell viability in all tested groups. However, this decrease was not significantly different from the control group. Thus, the prepared formulations can be considered promising alternatives for the delivery of ketoprofen in inflammatory diseases such as rheumatoid arthritis.
publishDate 2013
dc.date.none.fl_str_mv 2013-08-28
2015-02-25
2015-02-25
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv RIBAS, Daniele Adriane. DEVELOPMENT OF NANOCAPSULES CONTAINING KETOPROFEN AND in vitro EVALUATION OF CYTOTOXICITY. 2013. 67 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal de Santa Maria, Santa Maria, 2013.
http://repositorio.ufsm.br/handle/1/5989
dc.identifier.dark.fl_str_mv ark:/26339/0013000009dhd
identifier_str_mv RIBAS, Daniele Adriane. DEVELOPMENT OF NANOCAPSULES CONTAINING KETOPROFEN AND in vitro EVALUATION OF CYTOTOXICITY. 2013. 67 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal de Santa Maria, Santa Maria, 2013.
ark:/26339/0013000009dhd
url http://repositorio.ufsm.br/handle/1/5989
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
BR
Farmacologia
UFSM
Programa de Pós-Graduação em Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade Federal de Santa Maria
BR
Farmacologia
UFSM
Programa de Pós-Graduação em Ciências Farmacêuticas
dc.source.none.fl_str_mv reponame:Manancial - Repositório Digital da UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Manancial - Repositório Digital da UFSM
collection Manancial - Repositório Digital da UFSM
repository.name.fl_str_mv Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv atendimento.sib@ufsm.br||tedebc@gmail.com||manancial@ufsm.br
_version_ 1847153372493250560